The drug galcanezumab, initially known as LY2951742, represents the important breakthrough in migraine therapy. The chemical structure is that of the humanized monoclonal protein, specifically targeting calcitonin https://mediajx.com/story28036873/galcanezumab-a-deep-dive-into-ly2951742-and-its-chemical-identity